Revenue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.46B | $15.41B | $19.78B | $33.31B | $17.53B | $9.29B | $9.16B | $7.90B | $5.64B | $1.28B | $271.0M | $268.0M | $267.2M | $266.2M | $290.4M | $291.5M | $181.1M |
| Gross profit | $12.31B | $9.39B | $18.43B | $7.67B | $3.76B | $5.13B | $4.08B | $3.30B | $2.52B | $700.0M | — | — | — | — | — | — | — |
| Gross margin | 63.27% | 60.94% | 93.14% | 23.04% | 21.44% | 55.22% | 44.53% | 41.78% | 44.73% | 54.60% | — | — | — | — | — | — | — |
| Research & development | — | — | — | $16.0M | $7.0M | $6.0M | $9.0M | $7.0M | $10.0M | $7.0M | $42.0M | $54.4M | $60.9M | $66.1M | $40.8M | $12.0M | $223,000 |
| Operating expenses | $1.97B | $1.86B | $1.83B | $28.87B | $1.44B | $1.32B | $7.37B | $5.96B | $4.21B | $1.31B | $720.0M | $540.1M | $595.5M | $342.1M | $232.3M | $186.9M | $157.6M |
| Operating income | $9.11B | $6.13B | $15.49B | $4.56B | −$701.0M | $2.63B | $2.36B | $2.02B | $1.39B | −$30.0M | −$449.0M | −$272.2M | −$328.3M | −$75.8M | $58.1M | $104.6M | $23.5M |
| Operating margin | 46.81% | 39.76% | 78.30% | 13.69% | −4.00% | 28.31% | 25.78% | 25.63% | 24.59% | −2.34% | −165.68% | −101.58% | −122.87% | −28.48% | 20.02% | 35.89% | 12.97% |
| EBITDA | $10.44B | $7.35B | $16.68B | $5.68B | $310.0M | $3.56B | $3.15B | $2.47B | $1.74B | $144.0M | −$366.0M | −$207.9M | −$267.1M | −$9.4M | $121.6M | $167.9M | $77.7M |
| EBITDA margin | 53.64% | 47.67% | 84.35% | 17.05% | 1.77% | 38.34% | 34.45% | 31.32% | 30.89% | 11.23% | −135.06% | −77.60% | −99.96% | −3.54% | 41.85% | 57.59% | 42.91% |
| Net income | $5.33B | $3.25B | $9.88B | $1.43B | −$2.34B | −$85.0M | $648.0M | $471.0M | −$393.0M | −$610.0M | −$975.0M | −$547.9M | −$507.9M | −$332.8M | −$198.8M | −$76.2M | −$161.5M |
| Net profit margin | 27.38% | 21.10% | 49.95% | 4.29% | −13.36% | −0.91% | 7.08% | 5.97% | −6.96% | −47.58% | −359.78% | −204.49% | −190.08% | −125.00% | −68.43% | −26.14% | −89.16% |
| Basic EPSper basic share | $24.19 | $14.24 | $40.99 | $5.69 | -$9.25 | -$0.34 | $2.53 | $1.92 | -$1.68 | -$2.67 | -$4.30 | -$2.44 | -$2.32 | -$1.83 | -$2.60 | -$1.37 | -$3.13 |
| Diluted EPSper diluted share | $24.13 | $14.20 | $40.72 | $5.64 | -$9.25 | -$0.34 | $2.51 | $1.90 | -$1.68 | -$2.67 | -$4.30 | -$2.44 | -$2.32 | -$1.83 | -$2.60 | -$1.37 | -$3.13 |
Reported shareholders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 8.52%17.71M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 4.62%9.6M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.56%9.48M shares |
STATE STREET CORP | 2.86%5.94M shares |
FMR LLC | 2.38%4.94M shares |
MORGAN STANLEY | 2.20%4.57M shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.79%3.72M shares |
NORGES BANK | 1.72%3.58M shares |
CANADA PENSION PLAN INVESTMENT BOARD | 1.50%3.11M shares |
JPMORGAN CHASE & CO | 1.50%3.11M shares |
TORTOISE CAPITAL ADVISORS, L.L.C. | 1.41%2.94M shares |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1.27%2.63M shares |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.23%2.56M shares |
ROYAL BANK OF CANADA | 1.21%2.52M shares |
WELLINGTON MANAGEMENT GROUP LLP | 1.18%2.44M shares |
GOLDMAN SACHS GROUP INC | 1.13%2.36M shares |
DIMENSIONAL FUND ADVISORS LP | 1.10%2.28M shares |
D. E. Shaw & Co., Inc. | 1.04%2.16M shares |
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.03%2.14M shares |
BANK OF AMERICA CORP /DE/ | 1.03%2.13M shares |
Percentages use 207.9M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 30, 2026Form 4 | Davis ZachEVP & CFO | SellCommon Stock | 29.0K | $300.00 | $8.70M | 87.1K |
| Mar 27, 2026Form 4 | BOTTA G ANDREADirector | SellCommon Stock | 5.0K | $296.47 | $1.48M | 30.2K |
| Mar 26, 2026Form 4 | Feygin AnatolEVP & Chief Commercial Officer | SellCommon Stock | 10.2K | $291.24 | $2.98M | 147.1K |
| Mar 26, 2026Form 4 | Feygin AnatolEVP & Chief Commercial Officer | SellCommon Stock | 30.2K | $290.89 | $8.78M | 157.4K |
| Mar 26, 2026Form 4 | Markowitz Sean NEVP, CLO and Corp Sec | SellCommon Stock | 13.4K | $291.30 | $3.91M | 64.0K |